A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome

被引:59
作者
Khiali, Sajad [1 ]
Khani, Elnaz [1 ]
Entezari-Maleki, Taher [1 ,2 ]
机构
[1] Tabriz Univ Med Sci, Dept Clin Pharm, Fac Pharm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz, Iran
关键词
acute lung injury; ARDS; CRS; COVID-19; IL-6; SARS-CoV-2; tocilizumab; DRUG-METABOLIZING-ENZYMES; SARS-CORONAVIRUS; CYTOKINE STORM; RECEPTOR; IL-6; INTERLEUKIN-6; PATHOGENESIS; INFLAMMATION; PNEUMONIA; INFECTION;
D O I
10.1002/jcph.1693
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Currently, the world is facing the pandemic of a novel strain of beta-coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Acute respiratory distress syndrome (ARDS) is the most devastating complication of SARS-CoV-2. It was indicated that cytokine-release syndrome and dominantly interleukin (IL)-6 play a central role in the pathophysiology of ARDS related to the novel 2019 coronavirus disease (COVID-19). Despite the global emergency of the disease, at this time, there are no proven therapies for the management of the disease. Tocilizumab is a potential recombinant monoclonal antibody against IL-6 and currently is under investigation for the management of ARDS in patients with COVID-19. Given these points, we reviewed the current evidence regarding the potential therapeutic role of tocilizumab and its important clinical issues in the treatment of ARDS related to COVID-19.
引用
收藏
页码:1131 / 1146
页数:16
相关论文
共 86 条
  • [1] Consideration of the Aerosol Transmission for COVID-19 and Public Health
    Anderson, Elizabeth L.
    Turnham, Paul
    Griffin, John R.
    Clarke, Chester C.
    [J]. RISK ANALYSIS, 2020, 40 (05) : 902 - 907
  • [2] [Anonymous], 2020, WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 March 2020
  • [3] Could ferritin help the screening for COVID-19 in hemodialysis patients?
    Bataille, Stanislas
    Pedinielli, Nathalie
    Bergounioux, Jean-Phlippe
    [J]. KIDNEY INTERNATIONAL, 2020, 98 (01) : 235 - 236
  • [4] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
    Bettelli, E
    Carrier, YJ
    Gao, WD
    Korn, T
    Strom, TB
    Oukka, M
    Weiner, HL
    Kuchroo, VK
    [J]. NATURE, 2006, 441 (7090) : 235 - 238
  • [5] COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
    Bikdeli, Behnood
    Madhavan, Mahesh V.
    Jimenez, David
    Chuich, Taylor
    Dreyfus, Isaac
    Driggin, Elissa
    Der Nigoghossian, Caroline
    Ageno, Walter
    Madjid, Mohammad
    Guo, Yutao
    Tang, Liang V.
    Hu, Yu
    Giri, Jay
    Cushman, Mary
    Quere, Isabelle
    Dimakakos, Evangelos P.
    Gibson, C. Michael
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    Fareed, Jawed
    Caprini, Joseph A.
    Tafur, Alfonso J.
    Burton, John R.
    Francese, Dominic P.
    Wang, Elizabeth Y.
    Falanga, Anna
    McLintock, Claire
    Hunt, Beverley J.
    Spyropoulos, Alex C.
    Barnes, Geoffrey D.
    Eikelboom, John W.
    Weinberg, Ido
    Schulman, Sam
    Carrier, Marc
    Piazza, Gregory
    Beckman, Joshua A.
    Steg, Gabriel
    Stone, Gregg W.
    Rosenkranz, Stephan
    Goldhaber, Samuel Z.
    Parikh, Sahil A.
    Monreal, Manuel
    Krumholz, Harlan M.
    Konstantinides, Stavros V.
    Weitz, Jeffrey I.
    Lip, Gregory Y. H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (23) : 2950 - 2973
  • [6] Pulmonary epithelial barrier function: some new players and mechanisms
    Brune, Kieran
    Frank, James
    Schwingshackl, Andreas
    Finigan, James
    Sidhaye, Venkataramana K.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2015, 308 (08) : L731 - L745
  • [7] Anti-IL6R role in treatment of COVID-19-related ARDS
    Buonaguro, Franco Maria
    Puzanov, Igor
    Ascierto, Paolo Antonio
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [8] Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
    Castagne, Benjamin
    Viprey, Marie
    Martin, Julie
    Schott, Anne-Marie
    Cucherat, Michel
    Soubrier, Martin
    [J]. PLOS ONE, 2019, 14 (08):
  • [9] A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
    Chan, Jasper Fuk-Woo
    Yuan, Shuofeng
    Kok, Kin-Hang
    To, Kelvin Kai-Wang
    Chu, Hin
    Yang, Jin
    Xing, Fanfan
    Liu, Jieling
    Yip, Cyril Chik-Yan
    Poon, Rosana Wing-Shan
    Tsoi, Hoi-Wah
    Lo, Simon Kam-Fai
    Chan, Kwok-Hung
    Poon, Vincent Kwok-Man
    Chan, Wan-Mui
    Ip, Jonathan Daniel
    Cai, Jian-Piao
    Cheng, Vincent Chi-Chung
    Chen, Honglin
    Hui, Christopher Kim-Ming
    Yuen, Kwok-Yung
    [J]. LANCET, 2020, 395 (10223) : 514 - 523
  • [10] Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
    Channappanavar, Rudragouda
    Fehr, Anthony R.
    Vijay, Rahul
    Mack, Matthias
    Zhao, Jincun
    Meyerholz, David K.
    Perlman, Stanley
    [J]. CELL HOST & MICROBE, 2016, 19 (02) : 181 - 193